PMC:7306567 / 12555-12784
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
124 | 113-118 | Chemical | denotes | azole | MESH:D001393 |
125 | 201-206 | Chemical | denotes | azole | MESH:D001393 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T77 | 13-17 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T78 | 130-137 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T79 | 225-227 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T67 | 69-72 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
T68 | 113-118 | Chemical | denotes | azole | http://purl.obolibrary.org/obo/CHEBI_68452 |
T69 | 201-206 | Chemical | denotes | azole | http://purl.obolibrary.org/obo/CHEBI_68452 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T81 | 0-229 | Sentence | denotes | Patients who test positive require anti-Aspergillus therapy, and the BAL fluid sample should be fast-tracked for azole resistance testing by PCR (and culture when positive) in regions with high (> 5%) azole resistance rates [34]. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T91 | 69-78 | UBERON:0006314 | denotes | BAL fluid |
T92 | 113-118 | CHEBI:68452;CHEBI:68452 | denotes | azole |
T93 | 201-206 | CHEBI:68452;CHEBI:68452 | denotes | azole |
T22792 | 69-78 | UBERON:0006314 | denotes | BAL fluid |
T68159 | 113-118 | CHEBI:68452;CHEBI:68452 | denotes | azole |
T29336 | 201-206 | CHEBI:68452;CHEBI:68452 | denotes | azole |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32572532-30580035-47963427 | 225-227 | 30580035 | denotes | 34 |
T67090 | 225-227 | 30580035 | denotes | 34 |